CORRECTION: AbbVie Lowers FY2026 Adj EPS Guidance from $13.91-$14.11 to $13.87-$14.07 vs $14.08 Est

Benzinga Newsdesk www.benzinga.com Negative 96.3%

Neg 96.3% Neu 0% Pos 0%

AbbVie (NYSE:ABBV) lowers FY2026 Adj EPS guidance from $13.91-$14.11 to $13.87-$14.07 vs $14.08 analyst estimate..

Comments

No comments yet. Be the first!